Comment: cost comparison of recombinant human erythropoietin and blood transfusion in cancer chemotherapy-induced anemia.
Finkelstein
S N
SN
Huber
S L
SL
Greenberg
P E
PE
D000740:Anemia / Q000139:chemically induced* / Q000628:therapy*; D000970:Antineoplastic Agents / Q000009:adverse effects*; D001803:Blood Transfusion / Q000191:economics*; D003362:Cost-Benefit Analysis; D004921:Erythropoietin / Q000191:economics* / Q000627:therapeutic use; D006801:Humans
D000970:Antineoplastic Agents; D004921:Erythropoietin